Upcoming Events

  1. PCT Amsterdam
  2. OC17

    9th Global OpenClinica Congress 2017

    December 4 - December 5

Register Today!

Get Free Test Access

Cyntegrity and PPH plus build a strategic partnership to help customers embrace the RbM technology[:de]Cyntegrity and PPH plus build a strategic partnership to help customers embrace the RbM technology

Pharmaceutical companies often face staff and management resistance beyond other difficulties to embrace technological innovation. Processes are established and bonded to the internal and usual practice of staff members. To no surprise, risk-based monitoring is not a different case.

Therefore, in order to make the new procedures work, it is very important to have on-board an experienced project management team that can guide you through the change-management jungle.

Cyntegrity is happy to announce a strategic partnership with PPH plus, a german CRO that provides operational and consultancy services to biopharma for the international market place (clinical trials from phase I to IV).

PPH plus represents true expertise and project leadership acumen from early planning to study report writing as well as in-depth knowledge of overall drug development. Their highly experienced team, composed of medical doctors and project leaders with scientific background, has a deep understanding about the potential risks and risk indicators in a clinical study.

Cyntegrity and PPH plus offer a top service in the application and integration of the risk-based monitoring process in biopharmaceutical companies, other service providers and academia.

[:de]

Pharmaceutical companies often face staff and management resistance beyond other difficulties to embrace technological innovation. Processes are established and bonded to the internal and usual practice of staff members. To no surprise, risk-based monitoring is not a different case.

Therefore, in order to make the new procedures work, it is very important to have on-board an experienced project management team that can guide you through the change-management jungle.

Cyntegrity is happy to announce a strategic partnership with PPH plus, a german CRO that provides operational and consultancy services to biopharma for the international market place (clinical trials from phase I to IV).

PPH plus represents true expertise and project leadership acumen from early planning to study report writing as well as in-depth knowledge of overall drug development. Their highly experienced team, composed of medical doctors and project leaders with scientific background, has a deep understanding about the potential risks and risk indicators in a clinical study.

Cyntegrity and PPH plus offer a top service in the application and integration of the risk-based monitoring process in biopharmaceutical companies, other service providers and academia.

By | 2016-11-16T18:35:47+00:00 August 29, 2014|News|Comments Off on Cyntegrity and PPH plus build a strategic partnership to help customers embrace the RbM technology[:de]Cyntegrity and PPH plus build a strategic partnership to help customers embrace the RbM technology

About the Author:

Professional in the integration of data-driven Risk-based Monitoring (RbM) process in international clinical trials of pharmacology. Speaker at regional and global conferences such as: DIA, PharmaForum, PharmaDay, DGGF, etc. 10+ years of experience in data quality projects and biostatistics for the pharmaceutical industry. Life passion: improving clinical research with RbM, driving the RbM research to new frontiers for CROs, pharma and biotech companies.